相关实验视频

Updated: Sep 12, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

纳米粒子诱导的过度线粒与免疫检查点阻塞相结合,用于增强癌症免疫治疗

Yuan Cao¹, Rui Xu¹, Junyue Fang¹

¹Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China; Guangzhou Key Laboratory of Medical Nanomaterials, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.

Acta biomaterialia

|August 7, 2025

概括

这项研究引入了一种新型纳米平台,可以放大癌细胞中的线粒细胞吸收,抑制瘤生长并增强免疫疗法. 该平台沉默PD-L1并减少免疫抑制细胞,促进CD8+T细胞对抗乳腺癌的活性.

科学领域:

纳米医学是一种纳米医学.
癌症免疫疗法癌症免疫疗法
分子生物学分子生物学

背景情况:

瘤微环境 (TME) 通过影响免疫细胞来阻碍癌症免疫疗法.
细胞是一种细胞过程,影响细胞命运和免疫微环境.
向线粒菌提供了一种改善癌症免疫疗法的潜在策略.

研究的目的:

开发一种新的纳米平台,用于诱导线粒,以增强乳腺癌免疫疗法.
研究纳米平台在直接向癌细胞和调节TME方面的双重作用.

主要方法:

开发一个pH响应的纳米平台,封装一个线粒诱导剂 (CCCP) 和siRNA.
在体内利用了正位素和转移性乳腺癌模型.
评估纳米平台在诱导线粒,沉默PD-L1和改变免疫细胞透的有效性.

主要成果:

纳米平台有效地诱导了乳腺癌细胞的过度线粒,抑制了增殖.
实现了PD-L1表达的抑制,增强了CD8+ T细胞介导的抗瘤免疫力.
减少CCL2的分泌抑制了免疫抑制细胞 (TAMs,Tregs,MDSCs) 的透,重塑了TME.

结论:

开发的纳米平台是一个有前途的治疗工具,用于放大线粒和增强癌症免疫疗法.
这种方法协同结合了直接杀死瘤细胞与免疫微环境调节,以有效治疗乳腺癌.
该纳米平台显示出改善抗瘤免疫力和抑制瘤生长的巨大潜力.

关键词:

癌症免疫疗法癌症免疫疗法线粒细胞衰变 (mitophagy) 是一种细胞衰变的过程.一个纳米平台.干扰RNA (RNAi) 的一个例子.瘤微环境 (TME) 是指瘤的微环境.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...